EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    1.1.1.19 | Acute Kidney Injury |
30487609 |
Metabolic reprogramming by the S-nitroso-CoA reductase system protects against kidney injury. |
unassigned |
0 |
| 1.1.1.19 | Anemia |
33774021 |
Association between the genetic polymorphisms of the pharmacokinetics of anthracycline drug and myelosuppression in a patient with breast cancer with anthracycline-based chemotherapy. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
2
3
0 |
| 1.1.1.19 | Ascorbic Acid Deficiency |
28060768 |
A novel osteoporosis model with ascorbic acid deficiency in Akr1A1 gene knockout mice. |
causal interaction
ongoing research
therapeutic application
unassigned |
1
4
3
0 |
| 1.1.1.19 | Astrocytoma |
21276435 |
The role of aldehyde reductase AKR1A1 in the metabolism of gamma-hydroxybutyrate in 1321N1 human astrocytoma cells. |
diagnostic usage
ongoing research
unassigned |
3
4
0 |
| 1.1.1.19 | Astrocytoma |
23643085 |
[Effect of AKR1A1 knock-down on H2;O2; and 4-hydroxynonenal-induced cytotoxicity in human 1321N1 astrocytoma cells]. |
causal interaction
ongoing research
therapeutic application
unassigned |
1
4
1
0 |
| 1.1.1.19 | Breast Neoplasms |
33774021 |
Association between the genetic polymorphisms of the pharmacokinetics of anthracycline drug and myelosuppression in a patient with breast cancer with anthracycline-based chemotherapy. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
2
3
0 |
| 1.1.1.19 | Carcinoma, Hepatocellular |
25256836 |
Metabolism of gamma hydroxybutyrate in human hepatoma HepG2 cells by the aldo-keto reductase AKR1A1. |
ongoing research
unassigned |
3
0 |
| 1.1.1.19 | Diabetes Mellitus, Type 2 |
1661222 |
Activities of aldose reductase, ATPases, and nucleotide concentrations of erythrocytes in patients with type 2 (non-insulin-dependent) diabetes mellitus. |
causal interaction
diagnostic usage
ongoing research
unassigned |
3
1
4
0 |
| 1.1.1.19 | Laryngeal Neoplasms |
22555805 |
Increased aldehyde reductase expression mediates acquired radioresistance of laryngeal cancer cells via modulating p53. |
causal interaction
ongoing research
therapeutic application
unassigned |
3
2
3
0 |
| 1.1.1.19 | Liver Diseases, Alcoholic |
10510318 |
Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. |
diagnostic usage
unassigned |
3
0 |
